Berks Hematology-Oncology Associates — West Reading, Pennsylvania

Berks Hematology-Oncology Associates is a clinical research site located in West Reading, Pennsylvania, United States 19611.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Berks Hematology-Oncology Associates has participated in 2 clinical trials.

Therapeutic areas: Cachexia, B-Cell Chronic Lymphocytic Leukemia.

Sponsors: GTx, Celgene.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Berks Hematology-Oncology Associates?

Berks Hematology-Oncology Associates has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Berks Hematology-Oncology Associates conducted?

Berks Hematology-Oncology Associates has 2 clinical trials on record. Their work covers Cachexia, B-Cell Chronic Lymphocytic Leukemia.

Is Berks Hematology-Oncology Associates accredited by Crixeo Health?

Berks Hematology-Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Berks Hematology-Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.